Article

Variants in<i>STAU2</i>associate with metformin response in a type 2 diabetes cohort: a pharmacogenomics study using real-world electronic health record data

2020-03-20

Abstract excerpt

Type 2 diabetes mellitus (T2DM) is a major health and economic burden because of the seriousness of the disease and its complications. Improvements in short- and long-term glycemic control is the goal of diabetes treatment. To investigate the longitudinal management of T2DM at Geisinger, we interrogated the electronic health record (EHR) information and identified a T2DM cohort including 125,477 patients using the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 68d6d70e-90fe-5e50-9610-5ab4694e201a
DOI: 10.1101/2020.03.18.20037218

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Variants in<i>STAU2</i>associate with metformin response in a type 2 diabetes cohort: a pharmacogenomics study using real-world electronic health record dataDOI 10.1101/2020.03.18.20037218Read

Metformin Pharmacogenomics: Current Status and Future DirectionsSemantic proximity Read

Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.Semantic proximity Read

A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 DiabetesSemantic proximity Read

An Update on the Pharmacogenomics of Metformin: Progress, Problems and PotentialSemantic proximity Read

Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.Semantic proximity Read

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read

Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.Semantic proximity Read

Pharmacogenetics of Oral Antidiabetic DrugsSemantic proximity Read

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.Semantic proximity Read

Pharmacogenetics and personalized treatment of type 2 diabetesSemantic proximity Read

Pharmacogenetics of metformin response: a step in the path toward personalized medicine.Semantic proximity Read

Exome Sequence Data of Eight SLC Transporters Reveal That SLC22A1 and SLC22A3 Variants Alter Metformin Pharmacokinetics and Glycemic ControlSemantic proximity Read